Antimutagenic compounds and their possible mechanisms of action
Open Access
- 11 March 2014
- journal article
- review article
- Published by Springer Nature in Journal of Applied Genetics
- Vol. 55 (2) , 273-285
Abstract
Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described.Keywords
This publication has 98 references indexed in Scilit:
- The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a]pyridine derivativesEuropean Journal of Pharmacology, 2013
- Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogsDrug Design, Development and Therapy, 2013
- Antimutagenic and free radical scavenger effects of leaf extracts from Accacia salicinaAnnals of Clinical Microbiology and Antimicrobials, 2011
- Role of somatic mutations in vascular disease formationExpert Review of Molecular Diagnostics, 2010
- Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potentialBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- The antioxidant effects of vitamin A, C, and E on aflatoxin B1-induced oxidative stress in human lymphocytesToxicology and Industrial Health, 2009
- Detection of induced male germline mutation: Correlations and comparisons between traditional germline mutation assays, transgenic rodent assays and expanded simple tandem repeat instability assaysMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- β-Carotene: a cancer chemopreventive agent or a co-carcinogen?Mutation Research - Reviews in Mutation Research, 2003
- S‐allyl cysteine inhibits nitrosomorpholine formation and bioactivationNutrition and Cancer, 1997
- Assessment of antimutagenicity and anticarcinogenicityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992